With the approval of IMULDOSA, Accord BioPharma's (A division of Intas Pharmaceuticals) biosimilar portfolio continues to grow while expanding treatment…
Program offers expert guidance, coaching and community supportAddresses stress, anxiety, panic attacks, OCD and eating disordersCHENNAI, India, Oct. 11, 2024…